| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| GordonMD Global Investments LP | 7% | $23,275,071 | 3,058,485 | GordonMD Global Investments LP | 13 Nov 2025 |
As of 30 Sep 2025, 74 institutional investors reported holding 22,688,863 shares of Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share (KYTX). This represents 52% of the company’s total 43,692,643 outstanding shares.
The largest institutional shareholders of Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share (KYTX) together control 50% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Vida Ventures Advisors, LLC | 10% | 4,523,924 | 0% | 92% | $27,143,544 |
| GILEAD SCIENCES, INC. | 9.4% | 4,126,119 | 0% | 1.4% | $24,756,714 |
| Bain Capital Life Sciences Investors, LLC | 7.7% | 3,368,370 | 0% | 1.3% | $20,210,220 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3.5% | 1,512,199 | -17% | 0% | $9,074,000 |
| VANGUARD GROUP INC | 3% | 1,322,625 | +0.75% | 0% | $7,935,750 |
| Insight Holdings Group, LLC | 2.3% | 989,054 | 0% | 0.37% | $5,934,324 |
| FRANKLIN RESOURCES INC | 1.6% | 677,587 | -2.5% | 0% | $4,065,522 |
| MBB PUBLIC MARKETS I LLC | 1.4% | 614,477 | 0% | 0.49% | $3,686,862 |
| Catalio Capital Management, LP | 1.3% | 586,909 | 0% | 0.65% | $3,521,454 |
| MILLENNIUM MANAGEMENT LLC | 1.3% | 551,635 | +22% | 0% | $3,309,810 |
| BlackRock, Inc. | 1.1% | 482,054 | -9.6% | 0% | $2,892,324 |
| Kera Capital Partners, Inc. | 0.97% | 421,924 | 0% | 0.38% | $2,531,544 |
| Peapod Lane Capital LLC | 0.73% | 318,760 | -20% | 1.7% | $1,912,199 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.64% | 278,329 | -3.2% | 0% | $1,670,347 |
| Woodline Partners LP | 0.58% | 252,212 | 0.01% | $1,513,272 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.46% | 202,690 | +180% | 0% | $1,216,140 |
| JANE STREET GROUP, LLC | 0.46% | 198,851 | +127% | 0% | $1,193,106 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.4% | 174,900 | +178% | 0.02% | $1,049,400 |
| MORGAN STANLEY | 0.4% | 174,203 | -14% | 0% | $1,045,218 |
| TD Asset Management Inc | 0.38% | 164,796 | -35% | 0% | $988,776 |
| RENAISSANCE TECHNOLOGIES LLC | 0.38% | 164,614 | +34% | 0% | $987,684 |
| UBS Group AG | 0.36% | 157,422 | +60% | 0% | $944,532 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.34% | 147,712 | 0% | $886,272 | |
| TWO SIGMA INVESTMENTS, LP | 0.3% | 132,451 | +9.8% | 0% | $794,706 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.29% | 125,578 | +5.9% | 0% | $753,468 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 22,601 | $212,449 | +$16,920 | $9.40 | 3 |
| 2025 Q3 | 22,688,863 | $136,134,153 | -$2,158,017 | $6.00 | 74 |
| 2025 Q2 | 23,200,134 | $71,227,727 | -$5,373,744 | $3.07 | 77 |
| 2025 Q1 | 25,800,890 | $49,797,231 | -$8,775,592 | $1.93 | 86 |
| 2024 Q4 | 28,863,400 | $107,952,189 | -$6,920,913 | $3.74 | 87 |
| 2024 Q3 | 28,136,737 | $138,294,516 | -$28,965,516 | $4.89 | 92 |
| 2024 Q2 | 31,935,411 | $239,516,646 | -$86,044,405 | $7.50 | 87 |
| 2024 Q1 | 30,688,965 | $762,283,849 | +$760,773,578 | $24.84 | 88 |